Prasugrel and Ticagrelor: the Romulus and Remus of Antiplatelet Therapy?

Am J Cardiovasc Drugs. 2019 Aug;19(4):377-379. doi: 10.1007/s40256-019-00340-w.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acute Coronary Syndrome / drug therapy*
  • Humans
  • Platelet Aggregation Inhibitors / therapeutic use*
  • Prasugrel Hydrochloride / therapeutic use*
  • Purinergic P2Y Receptor Antagonists / therapeutic use*
  • Ticagrelor / therapeutic use*

Substances

  • Platelet Aggregation Inhibitors
  • Purinergic P2Y Receptor Antagonists
  • Prasugrel Hydrochloride
  • Ticagrelor